Table 5.

All-Cause Mortality Comparisons and Cox Proportional Hazard Model results

	Mortality		HR (95% CI)	p-value
	Yes (n=20)	No (n=180)
Study Group
AAV Subjects	12 (12.0%)	88 (88.0%)	1.97 (0.80, 4.87)	0.1402
Control Subjects	8 (8.0%)	92 (92.0%)
Gender
Male	14 (16.3%)	72 (83.7%)	3.19 (1.23, 8.31)	0.0174
Female	6 (5.3%)	108 (94.7%)
Visual Assessment
V-LAA- yes	13 (18.3%)	58 (81.7%)	3.43 (1.37, 8.61)	0.0085
V-LAA- no	7 (5.4%)	122 (94.6%)
Quantitative Assessment
Adj e950 >5%	7 (12.7%)	48 (87.3%)	1.56 (0.62, 3.91)	0.3440
Adj e950 <5%	13 (9.0%)	132 (91.0%)
Pulmonary Function Test
Obstruction	7 (14.6%)	41 (85.4%)	2.24 (0.88, 5.68)	0.0891
No obstruction	11 (7.9%)	128 (92.1%)
Multivariable Cox PH Model	HR	95% CI		Adjusted p-value
Age	1.10	1.05, 1.16		0.0002
Gender (M)	2.93	1.12, 7.69		0.0290
AAV	2.33	0.92, 5.90		0.0729

AAV= ANCA-associated Vasculitis, V-LAA= Visual Low attenuation areas